| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | DNA-dependent protein kinase activity | 1.56e-04 | 3 | 145 | 2 | GO:0004677 | |
| GeneOntologyMolecularFunction | histone H2AXS139 kinase activity | 1.56e-04 | 3 | 145 | 2 | GO:0035979 | |
| GeneOntologyMolecularFunction | Toll-like receptor 2 binding | 3.11e-04 | 4 | 145 | 2 | GO:0035663 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | STARD13 GRIPAP1 RASGRF1 DOCK11 RANBP3 ADGRB3 RGS4 ARHGEF10L RAB3GAP1 RGS18 ARHGEF7 ACAP2 | 3.36e-04 | 507 | 145 | 12 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | STARD13 GRIPAP1 RASGRF1 DOCK11 RANBP3 ADGRB3 RGS4 ARHGEF10L RAB3GAP1 RGS18 ARHGEF7 ACAP2 | 3.36e-04 | 507 | 145 | 12 | GO:0030695 |
| GeneOntologyMolecularFunction | histone H2AX kinase activity | 5.16e-04 | 5 | 145 | 2 | GO:0141003 | |
| GeneOntologyBiologicalProcess | meiotic chromosome segregation | 2.03e-07 | 122 | 145 | 9 | GO:0045132 | |
| GeneOntologyBiologicalProcess | homologous chromosome segregation | 1.28e-06 | 78 | 145 | 7 | GO:0045143 | |
| GeneOntologyBiologicalProcess | regulation of organelle organization | MYO1C TCP1 MDM1 MORC2 SMC2 RGS4 KIF20B WDPCP ARHGEF10L MAP3K4 TTBK2 SLC39A12 RAB3GAP1 VPS13D RESF1 ARHGEF7 BRD7 SNX18 WRAP73 ATM RUBCN TOP2A KNL1 TECPR1 BORA | 6.92e-06 | 1342 | 145 | 25 | GO:0033043 |
| GeneOntologyBiologicalProcess | reciprocal meiotic recombination | 7.63e-06 | 67 | 145 | 6 | GO:0007131 | |
| GeneOntologyBiologicalProcess | reciprocal homologous recombination | 7.63e-06 | 67 | 145 | 6 | GO:0140527 | |
| GeneOntologyBiologicalProcess | meiotic nuclear division | 7.88e-06 | 240 | 145 | 10 | GO:0140013 | |
| GeneOntologyBiologicalProcess | meiosis I | 9.62e-06 | 147 | 145 | 8 | GO:0007127 | |
| GeneOntologyBiologicalProcess | homologous recombination | 1.36e-05 | 74 | 145 | 6 | GO:0035825 | |
| GeneOntologyBiologicalProcess | meiosis I cell cycle process | 1.42e-05 | 155 | 145 | 8 | GO:0061982 | |
| GeneOntologyBiologicalProcess | chromosome organization involved in meiotic cell cycle | 1.47e-05 | 75 | 145 | 6 | GO:0070192 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle process | 2.05e-05 | 268 | 145 | 10 | GO:1903046 | |
| GeneOntologyBiologicalProcess | meiotic cell cycle | RNF212 PIWIL4 MORC2 SMC2 CEP63 MLH3 BRCA2 ATM TOP2A KNL1 TDRD12 | 3.84e-05 | 350 | 145 | 11 | GO:0051321 |
| GeneOntologyBiologicalProcess | nuclear chromosome segregation | RNF212 MORC2 SMC2 CEP63 MLH3 BRCA2 BRD7 WRAP73 ATM TOP2A KNL1 | 4.47e-05 | 356 | 145 | 11 | GO:0098813 |
| GeneOntologyBiologicalProcess | nuclear division | RNF212 MORC2 SMC2 KIF20B CEP63 MLH3 BRCA2 WRAP73 ATM TOP2A KNL1 BORA TDRD12 | 6.84e-05 | 512 | 145 | 13 | GO:0000280 |
| GeneOntologyBiologicalProcess | chromosome organization | TCP1 RNF212 MORC2 SMC2 MAP3K4 CEP63 MLH3 RESF1 BRCA2 BRD7 WRAP73 PRKDC ATM TOP2A KNL1 | 1.01e-04 | 686 | 145 | 15 | GO:0051276 |
| GeneOntologyBiologicalProcess | regulation of chromosome organization | 1.14e-04 | 266 | 145 | 9 | GO:0033044 | |
| GeneOntologyBiologicalProcess | homologous chromosome orientation in meiotic metaphase I | 1.47e-04 | 3 | 145 | 2 | GO:0031619 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipopeptide | 1.47e-04 | 3 | 145 | 2 | GO:0070340 | |
| GeneOntologyBiologicalProcess | positive regulation of chromosome organization | 1.48e-04 | 113 | 145 | 6 | GO:2001252 | |
| GeneOntologyBiologicalProcess | organelle fission | RNF212 MORC2 SMC2 KIF20B CEP63 MLH3 BRCA2 WRAP73 ATM TOP2A KNL1 BORA TDRD12 | 2.02e-04 | 571 | 145 | 13 | GO:0048285 |
| GeneOntologyBiologicalProcess | positive regulation of organelle organization | MYO1C TCP1 MORC2 SMC2 ARHGEF10L MAP3K4 TTBK2 RAB3GAP1 VPS13D RESF1 SNX18 WRAP73 ATM | 2.12e-04 | 574 | 145 | 13 | GO:0010638 |
| GeneOntologyBiologicalProcess | activation of NF-kappaB-inducing kinase activity | 2.15e-04 | 17 | 145 | 3 | GO:0007250 | |
| GeneOntologyBiologicalProcess | detection of bacterial lipoprotein | 2.92e-04 | 4 | 145 | 2 | GO:0042494 | |
| GeneOntologyBiologicalProcess | regulation of single stranded viral RNA replication via double stranded DNA intermediate | 3.04e-04 | 19 | 145 | 3 | GO:0045091 | |
| GeneOntologyBiologicalProcess | single stranded viral RNA replication via double stranded DNA intermediate | 3.55e-04 | 20 | 145 | 3 | GO:0039692 | |
| GeneOntologyBiologicalProcess | hematopoietic or lymphoid organ development | 3.59e-04 | 133 | 145 | 6 | GO:0048534 | |
| GeneOntologyBiologicalProcess | chromosome segregation | RNF212 MORC2 SMC2 CEP63 MLH3 BRCA2 BRD7 WRAP73 ATM TOP2A KNL1 | 4.58e-04 | 465 | 145 | 11 | GO:0007059 |
| GeneOntologyBiologicalProcess | microtubule-based process | CFAP47 MDM1 KIF20B WDPCP DNAH1 CEP63 CEP350 TTBK2 SLC39A12 DST BRCA2 NETO1 ARHGEF7 EHHADH CCSER2 WRAP73 BBS12 BORA | 4.59e-04 | 1058 | 145 | 18 | GO:0007017 |
| GeneOntologyBiologicalProcess | negative regulation of T-helper cell differentiation | 4.75e-04 | 22 | 145 | 3 | GO:0045623 | |
| GeneOntologyBiologicalProcess | presynaptic actin cytoskeleton organization | 4.84e-04 | 5 | 145 | 2 | GO:0099140 | |
| GeneOntologyBiologicalProcess | meiotic metaphase I homologous chromosome alignment | 4.84e-04 | 5 | 145 | 2 | GO:0043060 | |
| GeneOntologyBiologicalProcess | spleen development | 4.88e-04 | 52 | 145 | 4 | GO:0048536 | |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CFAP47 MDM1 DNAH1 CEP63 CEP350 TTBK2 SLC39A12 DST BRCA2 ARHGEF7 EHHADH CCSER2 WRAP73 BORA | 5.65e-04 | 720 | 145 | 14 | GO:0000226 |
| GeneOntologyCellularComponent | DNA repair complex | 1.87e-05 | 23 | 147 | 4 | GO:1990391 | |
| GeneOntologyCellularComponent | centriole | 2.19e-04 | 172 | 147 | 7 | GO:0005814 | |
| Domain | PH_dom-like | RASGRF1 DOCK11 RANBP3 SH3BP2 ANKS1B ARHGEF10L JAK3 ARHGEF7 TLN2 PLCL1 ACAP2 TECPR1 PHLPP2 | 2.85e-05 | 426 | 145 | 13 | IPR011993 |
| Domain | - | RASGRF1 DOCK11 RANBP3 SH3BP2 ANKS1B ARHGEF10L ARHGEF7 TLN2 PLCL1 ACAP2 TECPR1 PHLPP2 | 5.54e-05 | 391 | 145 | 12 | 2.30.29.30 |
| Domain | Secretoglobin_1C1/2 | 5.99e-05 | 2 | 145 | 2 | IPR028659 | |
| Domain | Ion_trans_dom | 2.65e-04 | 114 | 145 | 6 | IPR005821 | |
| Domain | Ion_trans | 2.65e-04 | 114 | 145 | 6 | PF00520 | |
| Domain | HATPase_c | 3.43e-04 | 18 | 145 | 3 | SM00387 | |
| Domain | HATPase_c | 4.05e-04 | 19 | 145 | 3 | PF02518 | |
| Domain | - | 4.74e-04 | 20 | 145 | 3 | 3.30.565.10 | |
| Domain | HATPase_C | 5.50e-04 | 21 | 145 | 3 | IPR003594 | |
| Domain | Toll-like_receptor | 5.89e-04 | 5 | 145 | 2 | IPR017241 | |
| Domain | FATC | 5.89e-04 | 5 | 145 | 2 | PF02260 | |
| Domain | TRP_2 | 8.80e-04 | 6 | 145 | 2 | PF08344 | |
| Domain | TRP_dom | 8.80e-04 | 6 | 145 | 2 | IPR013555 | |
| Domain | FAT | 8.80e-04 | 6 | 145 | 2 | PS51189 | |
| Domain | FATC | 8.80e-04 | 6 | 145 | 2 | PS51190 | |
| Domain | FAT | 8.80e-04 | 6 | 145 | 2 | PF02259 | |
| Domain | PIK-rel_kinase_FAT | 8.80e-04 | 6 | 145 | 2 | IPR003151 | |
| Domain | FATC_dom | 8.80e-04 | 6 | 145 | 2 | IPR003152 | |
| Domain | PIK_FAT | 8.80e-04 | 6 | 145 | 2 | IPR014009 | |
| Domain | FATC | 8.80e-04 | 6 | 145 | 2 | SM01343 | |
| Pubmed | Unpackaging the genetics of mammalian fertility: strategies to identify the "reproductive genome". | 5.36e-07 | 16 | 147 | 4 | 29878059 | |
| Pubmed | Functional interaction of monoubiquitinated FANCD2 and BRCA2/FANCD1 in chromatin. | 7.35e-07 | 5 | 147 | 3 | 15199141 | |
| Pubmed | Identification of genetic loci associated with Helicobacter pylori serologic status. | 2.56e-06 | 7 | 147 | 3 | 23652523 | |
| Pubmed | TET2 ADGRB3 SFI1 KBTBD2 CEMIP2 ARHGEF10L KMT2C DST ARHGEF7 CCSER2 RAI14 ACAP2 | 2.83e-06 | 529 | 147 | 12 | 14621295 | |
| Pubmed | Voltage-dependent conformational changes of Kv1.3 channels activate cell proliferation. | 3.13e-06 | 208 | 147 | 8 | 33230847 | |
| Pubmed | Real-time resolution of point mutations that cause phenovariance in mice. | 8.69e-06 | 10 | 147 | 3 | 25605905 | |
| Pubmed | TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin. | 8.82e-06 | 31 | 147 | 4 | 26095369 | |
| Pubmed | 1.45e-05 | 35 | 147 | 4 | 22337587 | ||
| Pubmed | 1.60e-05 | 74 | 147 | 5 | 35102251 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | GRIPAP1 AMER1 TCP1 CTIF KBTBD2 ECE1 CEP350 BRCA2 KLHL7 SNX18 WRAP73 TOP2A BORA BRWD1 | 1.68e-05 | 853 | 147 | 14 | 28718761 |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 38892470 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22315281 | ||
| Pubmed | Synthetic lethality between mutation in Atm and DNA-PK(cs) during murine embryogenesis. | 1.77e-05 | 2 | 147 | 2 | 11231155 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23163762 | ||
| Pubmed | Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. | 1.77e-05 | 2 | 147 | 2 | 10464290 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26470427 | ||
| Pubmed | Regulation of the DNA Damage Response by DNA-PKcs Inhibitory Phosphorylation of ATM. | 1.77e-05 | 2 | 147 | 2 | 27939942 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24012878 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21852947 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21487018 | ||
| Pubmed | Activation of DNA Damage Response Pathways during Lytic Replication of KSHV. | 1.77e-05 | 2 | 147 | 2 | 26057167 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26880370 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11123271 | ||
| Pubmed | NETO1 Regulates Postsynaptic Kainate Receptors in CA3 Interneurons During Circuit Maturation. | 1.77e-05 | 2 | 147 | 2 | 31044365 | |
| Pubmed | Kainate receptor auxiliary subunit NETO2 is required for normal fear expression and extinction. | 1.77e-05 | 2 | 147 | 2 | 30770891 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 29175392 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 11943477 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 19071136 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28474755 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 15464227 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 28680963 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 12065055 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17189255 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 22972376 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 26774662 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 37126020 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 23529130 | ||
| Pubmed | High expression of CPNE5 and CPNE9 predicts positive prognosis in multiple myeloma. | 1.77e-05 | 2 | 147 | 2 | 33780365 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24675808 | ||
| Pubmed | PLC-mediated PI(4,5)P2 hydrolysis regulates activation and inactivation of TRPC6/7 channels. | 1.77e-05 | 2 | 147 | 2 | 24470487 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 36727301 | ||
| Pubmed | Role of TLR1 and TLR6 in the host defense against disseminated candidiasis. | 1.77e-05 | 2 | 147 | 2 | 18036178 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24445834 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24984237 | ||
| Pubmed | Extreme Response to High-dose Testosterone in BRCA2- and ATM-mutated Prostate Cancer. | 1.77e-05 | 2 | 147 | 2 | 27692705 | |
| Pubmed | Deciphering the role of distinct DNA-PK phosphorylations at collapsed replication forks. | 1.77e-05 | 2 | 147 | 2 | 32674014 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 25261617 | ||
| Pubmed | Dendritic mechanisms controlling the threshold and timing requirement of synaptic plasticity. | 1.77e-05 | 2 | 147 | 2 | 20087888 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 21245310 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 34533610 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 17593081 | ||
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 24403160 | ||
| Pubmed | Targeting DNA-PKcs and ATM with miR-101 sensitizes tumors to radiation. | 1.77e-05 | 2 | 147 | 2 | 20617180 | |
| Pubmed | 1.77e-05 | 2 | 147 | 2 | 18172300 | ||
| Pubmed | Structure of human Roquin-2 and its complex with constitutive-decay element RNA. | 1.77e-05 | 2 | 147 | 2 | 26249698 | |
| Pubmed | A specific role for TLR1 in protective T(H)17 immunity during mucosal infection. | 1.77e-05 | 2 | 147 | 2 | 22778390 | |
| Pubmed | TPP2 TET2 FLI1 TCP1 MED14 MORC2 SMC2 TFAP2A KMT2C RESF1 CELF1 FANCI UBTF PRKDC TOP2A KNL1 | 1.88e-05 | 1103 | 147 | 16 | 34189442 | |
| Pubmed | TET2 COPB1 ADGRB3 ANKS1B CPNE5 CEP63 CEP350 DST KLHL7 NETO1 MICAL2 TLN2 RAI14 PRKDC JAKMIP1 ATM BRWD1 | 3.27e-05 | 1285 | 147 | 17 | 35914814 | |
| Pubmed | 3.52e-05 | 87 | 147 | 5 | 37495603 | ||
| Pubmed | Common genetic variants in candidate genes and risk of familial lymphoid malignancies. | 3.69e-05 | 145 | 147 | 6 | 19573080 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | 4.00e-05 | 582 | 147 | 11 | 20467437 | |
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | PRPSAP2 TPP2 COPB1 TCP1 MED14 MORC2 SMC2 MAP3K4 POLR3A RAB3GAP1 PRKDC TOP2A | 4.81e-05 | 704 | 147 | 12 | 29955894 |
| Pubmed | 5.08e-05 | 396 | 147 | 9 | 26687479 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25846551 | ||
| Pubmed | BRCA2 is required for neurogenesis and suppression of medulloblastoma. | 5.31e-05 | 3 | 147 | 2 | 17476307 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16081826 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15084244 | ||
| Pubmed | Inhibition of phosphoinositide 3-kinase related kinases by the radiosensitizing agent wortmannin. | 5.31e-05 | 3 | 147 | 2 | 9766667 | |
| Pubmed | Identification and characterization of FUS/TLS as a new target of ATM. | 5.31e-05 | 3 | 147 | 2 | 18620545 | |
| Pubmed | Genetic variation in the toll-like receptor gene cluster (TLR10-TLR1-TLR6) and prostate cancer risk. | 5.31e-05 | 3 | 147 | 2 | 18752252 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 30224064 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18644470 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 15731092 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18451257 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 29728365 | ||
| Pubmed | The D17Tu5 locus in the t complex: implications for the origin of t haplotypes and inbred strains. | 5.31e-05 | 3 | 147 | 2 | 2569442 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23836881 | ||
| Pubmed | Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland. | 5.31e-05 | 3 | 147 | 2 | 32875559 | |
| Pubmed | DNA Damage Signaling Is Required for Replication of Human Bocavirus 1 DNA in Dividing HEK293 Cells. | 5.31e-05 | 3 | 147 | 2 | 27733644 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23583642 | ||
| Pubmed | IFNs activate toll-like receptor gene expression in viral infections. | 5.31e-05 | 3 | 147 | 2 | 11607792 | |
| Pubmed | Association of 4p14 TLR locus with antibodies to Helicobacter pylori. | 5.31e-05 | 3 | 147 | 2 | 26312625 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 18451040 | ||
| Pubmed | TLR1- and TLR6-independent recognition of bacterial lipopeptides. | 5.31e-05 | 3 | 147 | 2 | 16455646 | |
| Pubmed | Roquin Paralogs Differentially Regulate Functional NKT Cell Subsets. | 5.31e-05 | 3 | 147 | 2 | 28188245 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 16177110 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 22150367 | ||
| Pubmed | Dynamic change of histone H2AX phosphorylation independent of ATM and DNA-PK in mouse skin in situ. | 5.31e-05 | 3 | 147 | 2 | 17923115 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 29101015 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 28526717 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 31601897 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 23626692 | ||
| Pubmed | Sequence variants in Toll-like receptor gene cluster (TLR6-TLR1-TLR10) and prostate cancer risk. | 5.31e-05 | 3 | 147 | 2 | 15812078 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 33414135 | ||
| Pubmed | Epistatic effect of TLR-1, -6 and -10 polymorphisms on organic dust-mediated cytokine response. | 5.31e-05 | 3 | 147 | 2 | 28123183 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 25205036 | ||
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 17611684 | ||
| Pubmed | Screening for ATM sequence alterations in African-American women diagnosed with breast cancer. | 5.31e-05 | 3 | 147 | 2 | 17333338 | |
| Pubmed | ATM phosphorylates histone H2AX in response to DNA double-strand breaks. | 5.31e-05 | 3 | 147 | 2 | 11571274 | |
| Pubmed | 5.31e-05 | 3 | 147 | 2 | 31164689 | ||
| GeneFamily | Transient receptor potential cation channels | 4.58e-04 | 28 | 98 | 3 | 249 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 8.97e-04 | 206 | 98 | 6 | 682 | |
| GeneFamily | Copines | 1.02e-03 | 9 | 98 | 2 | 829 | |
| GeneFamily | CD molecules|Toll like receptors | 1.27e-03 | 10 | 98 | 2 | 948 | |
| GeneFamily | Secretoglobins | 2.54e-03 | 14 | 98 | 2 | 734 | |
| GeneFamily | Chaperonins | 2.92e-03 | 15 | 98 | 2 | 587 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 5.19e-03 | 20 | 98 | 2 | 548 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 5.52e-03 | 66 | 98 | 3 | 722 | |
| GeneFamily | Bardet-Biedl syndrome associated|BBSome | 5.71e-03 | 21 | 98 | 2 | 980 | |
| GeneFamily | Regulators of G-protein signaling | 5.71e-03 | 21 | 98 | 2 | 720 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 6.09e-03 | 134 | 98 | 4 | 861 | |
| Coexpression | RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP | RC3H2 SMC2 TFAP2A KIF20B CEP63 KMT2C RESF1 BRCA2 MICAL2 KCNMA1 ACAP2 TOP2A KNL1 BORA BRWD1 | 1.39e-05 | 721 | 147 | 15 | M10237 |
| Coexpression | GSE17721_LPS_VS_POLYIC_2H_BMDC_UP | 1.80e-05 | 200 | 147 | 8 | M3801 | |
| Coexpression | GSE20366_TREG_VS_TCONV_DN | 1.80e-05 | 200 | 147 | 8 | M4312 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000 | FLI1 CPNE9 EFCAB6 DOCK11 ATAD5 ICE2 MDM1 SFI1 SMC2 CYP39A1 C8orf34 KIF20B CEMIP2 ZFHX4 BRCA2 COPS8 BRD7 TRPM1 KNL1 BORA BRWD1 | 2.11e-06 | 989 | 140 | 21 | Facebase_RNAseq_e10.5_Maxillary Arch_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#3 | ATAD5 ICE2 MDM1 SMC2 C8orf34 KIF20B ZFHX4 BRCA2 BRD7 TRPM1 KNL1 BORA BRWD1 | 5.91e-06 | 432 | 140 | 13 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K3 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_top-relative-expression-ranked_1000 | BOC FLI1 AMER1 TRPC7 TCP1 ATAD5 TRPC6 CYP39A1 CEP350 ADAMTS12 RESF1 ZFHX4 BRCA2 KCND2 KLHL7 COPS8 TOP2A LARGE1 | 9.27e-06 | 831 | 140 | 18 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500 | FLI1 EFCAB6 ICE2 MDM1 SMC2 CYP39A1 TFAP2A KIF20B CEMIP2 ZFHX4 BRCA2 COPS8 FDFT1 | 2.34e-05 | 492 | 140 | 13 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | ATAD5 TRPC6 SMC2 KIF20B RGS18 MANSC1 BRCA2 NETO2 RAI14 TOP2A KNL1 BORA | 2.45e-05 | 423 | 140 | 12 | GSM791126_500 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.35e-05 | 136 | 140 | 7 | gudmap_developingGonad_e14.5_ testes_1000_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 4.17e-05 | 192 | 140 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_500_K4 | |
| CoexpressionAtlas | B cells, B.GC.Sp, CD19+ IgM+ IgD- GL7+ PNA+, Spleen, avg-3 | SEMA7A ATAD5 SMC2 CYP39A1 CLEC12A KIF20B FANCI TLR1 RUBCN TOP2A KNL1 | 4.51e-05 | 380 | 140 | 11 | GSM538207_500 |
| CoexpressionAtlas | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | 7.81e-05 | 270 | 140 | 9 | gudmap_RNAseq_p2_Glomerlular Endothelial_2500_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500 | BOC TPP2 IL12RB2 ATAD5 ICE2 MDM1 MED14 ANKS1B SMC2 TFAP2A KIF20B GFRA2 CEP350 BRCA2 NETO2 FDFT1 BRD7 TRPM1 ATM TOP2A KNL1 BORA BRWD1 | 8.17e-05 | 1459 | 140 | 23 | facebase_RNAseq_e10.5_Emin_LatNas_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500 | CPNE9 EFCAB6 DOCK11 ATAD5 MDM1 SFI1 SMC2 C8orf34 KIF20B ZFHX4 BRCA2 TRPM1 | 1.04e-04 | 492 | 140 | 12 | Facebase_RNAseq_e10.5_Maxillary Arch_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Fetal Liver, avg-1 | ATAD5 SMC2 CLEC12A KIF20B GFRA2 RGS18 BRCA2 FANCI TOP2A KNL1 BORA | 1.15e-04 | 422 | 140 | 11 | GSM538357_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_k-means-cluster#2_top-relative-expression-ranked_1000 | 1.65e-04 | 234 | 140 | 8 | gudmap_developingKidney_e15.5_Peripheral blastema_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_k-means-cluster#2_top-relative-expression-ranked_500 | 1.77e-04 | 79 | 140 | 5 | gudmap_developingGonad_e14.5_ testes_500_k2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MaxArch_2500_K3 | TPP2 TET2 FLI1 IL12RB2 ATAD5 ICE2 MDM1 SFI1 SMC2 TFAP2A KIF20B GFRA2 RESF1 BRCA2 NETO2 EHHADH FDFT1 BRD7 ATM KNL1 | 2.11e-04 | 1252 | 140 | 20 | facebase_RNAseq_e10.5_MaxArch_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | TPP2 DOCK11 ATAD5 SMC2 KIF20B MAP3K4 CEP63 BRCA2 BRD7 PRKDC ATM BBS12 | 2.16e-04 | 532 | 140 | 12 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | BOC TPP2 IL12RB2 ATAD5 ICE2 MDM1 MED14 SMC2 KIF20B GFRA2 CEP350 BRCA2 NETO2 FDFT1 BRD7 ATM TOP2A KNL1 BORA BRWD1 | 2.22e-04 | 1257 | 140 | 20 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.26e-04 | 311 | 140 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K2 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500 | TPP2 FLI1 IL12RB2 ATAD5 ICE2 MDM1 SOSTDC1 SMC2 RGS4 KIF20B GFRA2 S100A3 RESF1 BRCA2 NETO2 BRD7 TRPM1 BBS12 TOP2A KNL1 BORA BRWD1 | 2.44e-04 | 1468 | 140 | 22 | facebase_RNAseq_e10.5_MandArch_2500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | CPNE9 EFCAB6 ATAD5 MDM1 SMC2 KIF20B DST BRCA2 BRD7 PRKDC BORA | 2.86e-04 | 469 | 140 | 11 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_1000 | RC3H2 AMER1 SEMA7A DOCK11 DPPA2 SMC2 ECE1 CEMIP2 RESF1 KCND2 UBTF JAKMIP1 TOP2A KNL1 TDRD12 | 2.86e-04 | 806 | 140 | 15 | gudmap_developingGonad_e12.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 2.96e-04 | 255 | 140 | 8 | Facebase_RNAseq_e10.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | alpha beta T cells, T.DPbl.Th, 4+ 8+ TCR-/lo FSChi, Thymus, avg-3 | 3.16e-04 | 398 | 140 | 10 | GSM399397_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Peripheral blastema_emap-27731_top-relative-expression-ranked_1000 | STARD13 BOC FLI1 DOCK11 ATAD5 MED14 KIF20B TTBK2 NETO2 KCND2 KLHL7 SCN1A TLR1 PLCL1 BRWD1 | 3.39e-04 | 819 | 140 | 15 | gudmap_developingKidney_e15.5_Peripheral blastema_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | PRPSAP2 TCP1 ICE2 DPPA2 CPNE5 KMT2C BRCA2 NETO2 FANCI PRMT9 PRKDC ATM CHURC1 BRWD1 TDRD12 | 3.43e-04 | 820 | 140 | 15 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 3.60e-04 | 92 | 140 | 5 | GSM791126_100 | |
| CoexpressionAtlas | B cells, preB.FrC.BM, CD19+ IgM- CD45R+ CD43+ HSA+, Bone marrow, avg-3 | 3.91e-04 | 409 | 140 | 10 | GSM399452_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.99e-04 | 336 | 140 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | Fetal Liver, SC.STSL.FL, IgM- CD24- CD117+ IL7R- CD150- CD48- AA4.1+ CD43+, Fetal Liver, avg-2 | 3.99e-04 | 410 | 140 | 10 | GSM791122_500 | |
| CoexpressionAtlas | alpha beta T cells, T.8Eff.Sp.OT1.d5.VSVOva, CD8+ CD45.1+, Spleen, avg-3 | 3.99e-04 | 410 | 140 | 10 | GSM538387_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Mandibular Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.05e-04 | 203 | 140 | 7 | Facebase_RNAseq_e9.5_Mandibular Arch_1000_K4 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | RC3H2 MYO1C SEMA7A DPPA2 PIWIL4 ECE1 CEMIP2 JAK3 RESF1 TDRD12 | 4.07e-04 | 411 | 140 | 10 | gudmap_developingGonad_e14.5_ testes_500 |
| CoexpressionAtlas | Stem Cells, SC.ST34F.BM, Lineage- cKit+ Sca-1+ flk2- CD34+, Bone marrow, avg-2 | 4.07e-04 | 411 | 140 | 10 | GSM791112_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Mandibular Arch_top-relative-expression-ranked_2500_k-means-cluster#3 | BOC FLI1 FAM114A1 CPNE9 ICE2 MDM1 SMC2 KIF20B GFRA2 ZFHX4 BRCA2 FDFT1 TRPM1 KNL1 TECPR1 | 4.10e-04 | 834 | 140 | 15 | Facebase_RNAseq_e10.5_Mandibular Arch_2500_K3 |
| CoexpressionAtlas | B cells, B.Fo.MLN, CD19+ CD45R+ CD23+ CD21/35+, Lymph Node, avg-3 | 4.53e-04 | 342 | 140 | 9 | GSM777021_500 | |
| CoexpressionAtlas | alpha beta T cells, T.ISP.Th, 4- 8+ TCR-/lo 24hi, Thymus, avg-3 | 4.55e-04 | 417 | 140 | 10 | GSM399403_500 | |
| CoexpressionAtlas | gamma delta T cells, Tgd.vg3+24alo.e17.Th, TCRd+ Vg3+ CD24-, Fetal Thymus, avg-3 | 4.73e-04 | 419 | 140 | 10 | GSM476664_500 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2B.Th, Lin-/lo CD25hi CD44+ cKitint, Thymus, avg-2 | IL12RB2 ATAD5 SMC2 CLEC12A RGS18 BRCA2 FANCI TOP2A KNL1 BORA | 4.82e-04 | 420 | 140 | 10 | GSM791141_500 |
| CoexpressionAtlas | B cells, proB.FrA.FL, CD19- IgM- CD43+ CD24intermediate AA4.1+ CD45R+ CD, Fetal Liver, avg-2 | 5.00e-04 | 422 | 140 | 10 | GSM538355_500 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_MandArch_2500_K1 | TPP2 FLI1 IL12RB2 ATAD5 ICE2 MDM1 SMC2 KIF20B GFRA2 S100A3 RESF1 BRCA2 NETO2 BRD7 BBS12 TOP2A KNL1 BORA BRWD1 | 5.19e-04 | 1241 | 140 | 19 | facebase_RNAseq_e10.5_MandArch_2500_K1 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | BOC TET2 FAM114A1 AMER1 SEMA7A TCP1 ATAD5 TRPC6 SOSTDC1 GFRA2 BRCA2 NETO2 MICAL2 TOP2A | 5.64e-04 | 768 | 140 | 14 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 5.80e-04 | 354 | 140 | 9 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | BOC TET2 FAM114A1 AMER1 SEMA7A ATAD5 TRPC6 SOSTDC1 GFRA2 CEP350 NETO2 MICAL2 FDFT1 TOP2A | 6.01e-04 | 773 | 140 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_top-relative-expression-ranked_200 | 6.17e-04 | 157 | 140 | 6 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_200 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | IL12RB2 ATAD5 ICE2 MDM1 CTIF SFI1 SMC2 KIF20B WDPCP GFRA2 CEMIP2 BRCA2 NETO2 ARHGEF7 ATM KNL1 BRWD1 | 6.22e-04 | 1060 | 140 | 17 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ ovary_emap-6699_top-relative-expression-ranked_1000 | RC3H2 DOCK11 ICE2 DPPA2 SMC2 ECE1 KMT2C RESF1 BRCA2 KCND2 JAKMIP1 ATM CHURC1 TDRD12 | 6.24e-04 | 776 | 140 | 14 | gudmap_developingGonad_e14.5_ ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#4 | 6.41e-04 | 359 | 140 | 9 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Lateral Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 7.09e-04 | 291 | 140 | 8 | Facebase_RNAseq_e10.5_Lateral Nasal Eminence_1000_K3 | |
| CoexpressionAtlas | NK cells, NK.MCMV1.Sp, CD3-,NK1.1+, Spleen, avg-3 | 7.50e-04 | 367 | 140 | 9 | GSM538309_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | ATAD5 ICE2 MDM1 ADGRB3 MED14 KIF20B CEMIP2 CEP63 TTBK2 BRCA2 NETO2 ARHGEF7 PRKDC KNL1 TECPR1 BRWD1 | 8.26e-04 | 989 | 140 | 16 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#4 | 8.27e-04 | 298 | 140 | 8 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K4 | |
| CoexpressionAtlas | kidney_adult_CortVasc_Tie2_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.01e-04 | 302 | 140 | 8 | gudmap_kidney_adult_CortVasc_Tie2_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#2_top-relative-expression-ranked_1000 | 9.96e-04 | 115 | 140 | 5 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k2_1000 | |
| ToppCell | Dividing_Macrophages-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 1.63e-08 | 191 | 148 | 9 | 3e567ed6b5fefafa7f460e49d25d60bb52a0a6c8 | |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.87e-08 | 194 | 148 | 9 | dff3fb10372053951d41e0ccd41aac3ece6009bd | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells-Neuroepithelial_cell|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.43e-08 | 200 | 148 | 9 | 0d9b8d51a7630e70e60c76c763ff82df4c559152 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Stem_cells|2m / Sample Type, Dataset, Time_group, and Cell type. | 2.43e-08 | 200 | 148 | 9 | 0675f580ccef705875854247bbfd4ee2bcf126a1 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-FOXM1|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.64e-07 | 180 | 148 | 8 | 334e2b1f6eb7d4ece20b1c7b02107863f913237f | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.86e-07 | 183 | 148 | 8 | a716b446c2bf5aa294b8f580aa845098fae76354 | |
| ToppCell | Dividing_Macrophages-IPF_01|World / lung cells shred on cell class, cell subclass, sample id | 1.94e-07 | 184 | 148 | 8 | f15ce786d25c6546804a6d1efcc2ad645f2ef54e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.02e-07 | 185 | 148 | 8 | 30e041d6f6e310d64809e9d6d93cd30052972f3b | |
| ToppCell | TCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9 | 2.11e-07 | 186 | 148 | 8 | 03db813598b67b1e08f759758a1c2023396921fa | |
| ToppCell | Control-Endothelial-Endothelial-FOXM1|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-07 | 189 | 148 | 8 | 1e1499b062d9c647c8f38b0c4e0d871d159be5dd | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-07 | 191 | 148 | 8 | 912e2d10d3423aa7f708fcf2b11da1845f12d7d3 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.58e-07 | 191 | 148 | 8 | bae388e0e9447d576e68465d73d8313ef6925ffa | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Lymphoid-CD4/CD8-Prolif_T|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.58e-07 | 191 | 148 | 8 | 77a2746b6d9c53b08d4405411c16fcc5a6c734ce | |
| ToppCell | Severe_COVID-19-Myeloid-proliferating_Myeloid_cells|Severe_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.80e-07 | 193 | 148 | 8 | 0d85025690c9cd545cba30abc38acbdd6a39b153 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-07 | 194 | 148 | 8 | cb39850e9577015b6b9834e98c36b412bae7d462 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-07 | 194 | 148 | 8 | 408597c9aa302a44b112c1d612c21fbb0227a82a | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.91e-07 | 194 | 148 | 8 | 193cc20fefbd795a4ad59e401a95af47d30603e7 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.91e-07 | 194 | 148 | 8 | 2360b5f995b360419de41612368cab9fb61781a1 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid-proliferating_Myeloid_cells|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-07 | 194 | 148 | 8 | 903ae11708b0cb24538c6982abd57fe6fa95b8d3 | |
| ToppCell | BAL-Severe-Myeloid-Myeloid|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.91e-07 | 194 | 148 | 8 | 58406502a8cbcc3037f79a1b6a683df408297ae5 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.27e-07 | 197 | 148 | 8 | 0b1fa881abbfcc54b322fc27124db3f8947af016 | |
| ToppCell | proximal-3-Hematologic-Proliferating_Macrophage|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.27e-07 | 197 | 148 | 8 | 0dd9058aa19d1268ebba9a65555870224b5a5978 | |
| ToppCell | proximal-Hematologic-Proliferating_Macrophage-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.27e-07 | 197 | 148 | 8 | 9243617b307acf3df40d93c41cd8d4788699a7ea | |
| ToppCell | critical-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 3.67e-07 | 200 | 148 | 8 | f39db4250ce220a3eb58edee3f7fc3671701d46f | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Proliferating|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 3.67e-07 | 200 | 148 | 8 | cea58274efbe7f9e3c3ef9fbb768ebfb917e21d9 | |
| ToppCell | Non-neuronal-Dividing-IPC|World / Primary Cells by Cluster | 3.67e-07 | 200 | 148 | 8 | 971533181daa1bfac1f1b8c507d2013f891f9078 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 162 | 148 | 7 | fc313fb2c55957faa8c9ca4023b3fce63527c267 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell-B_cells-B_cells_L.1.5.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 162 | 148 | 7 | 002fac3c5c3030950f9eb9e887d59902586d8452 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 162 | 148 | 7 | 08b7f06580d516307516d5475a5dae0fa040f1a4 | |
| ToppCell | 3'-Airway_Nasal-Immune_Lymphocytic-Lymphocytic_B-B_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 162 | 148 | 7 | 1fda21a303a08aff6f97819cd8766cd18784d8bc | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-06 | 167 | 148 | 7 | 1bd27ffe381d26731b6d4cc5f29b27f1bac4473b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Cycling_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.47e-06 | 167 | 148 | 7 | bc132b51dec4e8f1cd2b2cd89f83641976e09292 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-06 | 169 | 148 | 7 | e7514956b2e4298222ec443f98b2f5289451786e | |
| ToppCell | LPS-IL1RA+antiTNF-Endothelial-Endothelial-FOXM1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.60e-06 | 169 | 148 | 7 | e0607af8ae8609d43e26ff2a2cab92650bfcd5b7 | |
| ToppCell | 367C-Lymphocytic-NK_cells-Proliferating_NK_cell|367C / Donor, Lineage, Cell class and subclass (all cells) | 1.73e-06 | 171 | 148 | 7 | 4ede6e916e593f208f2f8ccf82ef2335e061fc86 | |
| ToppCell | P15-Mesenchymal-developing_mesenchymal_cell-mesenchymal_proliferating_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.79e-06 | 172 | 148 | 7 | 7c238a7375341d4647ba7274d93fddfb6fae7ce4 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.01e-06 | 175 | 148 | 7 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.01e-06 | 175 | 148 | 7 | 876cea684faf42ff3eb4623ad6d7a1fb1276ee02 | |
| ToppCell | PND01-Endothelial-Endothelial_blood-vessel-Microvascular_EC-EPC-EPC_G2M|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.09e-06 | 176 | 148 | 7 | 8385435074cc5235b7af7424974f609388fc2cff | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.34e-06 | 179 | 148 | 7 | 88d44b04eb5c079531db663ed98ddb20b60feb9a | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_3|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-06 | 181 | 148 | 7 | b193f3606554adc55c5906219d114288bb1f978a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling-Cycling_Connecting_Tubule_Cell_G2M|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.61e-06 | 182 | 148 | 7 | 336cd05e46a741185ce3c59ee67a4b07fa6a5101 | |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 2.71e-06 | 183 | 148 | 7 | a48a6313f2f144586951cece97ec31f6d72361df | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-06 | 184 | 148 | 7 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | Control-T_cells-Cycling_NK/T_cells|Control / group, cell type (main and fine annotations) | 2.91e-06 | 185 | 148 | 7 | 9766216b41ee62bbac4caa25cb98ec5627a24075 | |
| ToppCell | 10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_T_cell|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-06 | 185 | 148 | 7 | 9d424a8608b339dd6129c58d87626678d4ec4af7 | |
| ToppCell | Dividing_Macrophages-Myositis-ILD_01|World / lung cells shred on cell class, cell subclass, sample id | 3.01e-06 | 186 | 148 | 7 | 0067eb78d4c7e32b9563550d9fcaf13445ee6a48 | |
| ToppCell | 368C-Myeloid-Dendritic-cDC_proliferating_1|Dendritic / Donor, Lineage, Cell class and subclass (all cells) | 3.01e-06 | 186 | 148 | 7 | 5cadab3271fce9ab6da3d7ba9827b8a221cac166 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 187 | 148 | 7 | e41e39fd3791acf8ae5376cc5061e196d96868ae | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 187 | 148 | 7 | cefa211ef224e803ea9467882e2ca74d0b1492f1 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 187 | 148 | 7 | 9351fa87b69a951af85b10bf91fe9b1cce8c0517 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_connecting_tubule_epithelial_cell_cycling|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.12e-06 | 187 | 148 | 7 | 057569c9437219ecc396aa6e673b1178a2273837 | |
| ToppCell | Striatum-Neuronal-Excitatory-eN3(Slc17a7_Gad1Gad2)|Striatum / BrainAtlas - Mouse McCarroll V32 | 3.23e-06 | 188 | 148 | 7 | e34ea7014c5a059a7db38f78bd903cf02616ddd3 | |
| ToppCell | NS-critical-d_0-4-Lymphoid-NKT-proliferating|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.35e-06 | 189 | 148 | 7 | d6bd46abb072b13a6b72f1ca25d19f218cceb1ff | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 3.35e-06 | 189 | 148 | 7 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Dividing_Macrophages-SSc-ILD_02|World / lung cells shred on cell class, cell subclass, sample id | 3.35e-06 | 189 | 148 | 7 | d4e88a3e50499d683e3db38aee04490146fe30bb | |
| ToppCell | PBMC-Severe-cDC_12|Severe / Compartment, Disease Groups and Clusters | 3.47e-06 | 190 | 148 | 7 | 84ee185939bdefb10705b621a70da27701eadcee | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating-Alveolar_macrophage_proliferating_L.1.0.7.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-06 | 191 | 148 | 7 | d6e158f16a183c9203c057192342e9b83e79bc89 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophage_proliferating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.59e-06 | 191 | 148 | 7 | 7cb5c6f2cf27f3503d1b313e402a7410dfe6473e | |
| ToppCell | 3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Cycling_T|bone_marrow / Manually curated celltypes from each tissue | 3.59e-06 | 191 | 148 | 7 | 210a0f1a71df2508cbfc73d6868a2122338b9a1c | |
| ToppCell | Mild-T/NK_proliferative|World / Disease group and Cell class | 3.59e-06 | 191 | 148 | 7 | 9dba5526fd5ea8065ad305feb2ee562335f887c6 | |
| ToppCell | RV-08._Macrophage|World / Chamber and Cluster_Paper | 3.72e-06 | 192 | 148 | 7 | a1b5dc5beb97a23729b97b54fb4574d10d8fbfb3 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.72e-06 | 192 | 148 | 7 | 1c0ce299cee9ab5cdea256f3e8c1e5598577a8b6 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 3.72e-06 | 192 | 148 | 7 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-06 | 193 | 148 | 7 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | human_hepatoblastoma-Tumor_cells-T1|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 3.85e-06 | 193 | 148 | 7 | 4b9fa2a4424f8abe63fa7bee78db93dda04ab15f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 3.85e-06 | 193 | 148 | 7 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 3.85e-06 | 193 | 148 | 7 | ccab6a0c76f574ef7e1d6d5f1e620376daf21bbf | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.85e-06 | 193 | 148 | 7 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.98e-06 | 194 | 148 | 7 | 17af04acd54dd6a895a966cbb4422de25dc4f1e6 | |
| ToppCell | (3)_Chondrocytes-(33)_Chondro-prol/rest|(3)_Chondrocytes / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.98e-06 | 194 | 148 | 7 | 4a207630d72059345b10010f5cfd3b1462458324 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 3.98e-06 | 194 | 148 | 7 | f9070035553bc68106a9e0bdf4b507715a138aba | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.98e-06 | 194 | 148 | 7 | 3c385d93c5fe1a7817813c492f79fdb94d887357 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil-Neu_4|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 3.98e-06 | 194 | 148 | 7 | 23318a1b55895b5166c6151f488a94a09b4627ff | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic-lymphocyte|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.98e-06 | 194 | 148 | 7 | 635d0e88f9c542a1d9363066c6cdbc6e44db76c1 | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.98e-06 | 194 | 148 | 7 | a12b64945e10f00aa983678a02586c59badc1570 | |
| ToppCell | COVID-19-kidney-Proliferating_T_cell|kidney / Disease (COVID-19 only), tissue and cell type | 4.12e-06 | 195 | 148 | 7 | 7e05e56f8d0a7a052830c7db12b10dace7d10760 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Macrophage_Dendritic-Cycling_Mononuclear_Phagocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.12e-06 | 195 | 148 | 7 | db1660ce74819cd816bdcfcae5efb3aad82cce66 | |
| ToppCell | COVID-19-T_cells-Cycling_NK/T_cells|COVID-19 / group, cell type (main and fine annotations) | 4.12e-06 | 195 | 148 | 7 | 764ed100c28d9bc93ee5ecabc5291c8f184d78da | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 195 | 148 | 7 | 926eb3fc5d028be936885bea0654a77db3107234 | |
| ToppCell | mild-Lymphocytic-Prol._cells|mild / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 4.12e-06 | 195 | 148 | 7 | 9a8cc9097a349fd0a53ccf2723ee8bb1418d6aca | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 4.12e-06 | 195 | 148 | 7 | 1a5e814e12fe37287dbfc58189e1958e2c76b5da | |
| ToppCell | 5'-Parenchyma_lung-Immune_Lymphocytic-Lymphocytic_T/NK-natural_killer_cell-NK_cells-NK_cells_L.1.3.2.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.26e-06 | 196 | 148 | 7 | 76f581e35967f8f7c85a8556129f6e8042ad11ca | |
| ToppCell | 367C-Myeloid-Macrophage-FABP4+_Macrophage_proliferating|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.26e-06 | 196 | 148 | 7 | 9591a6a3477ed6a1e2e016f7542e38603d8b16cb | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Proliferating-Cycling_Progenitors|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 4.26e-06 | 196 | 148 | 7 | 5905f0e3061a6b98b7a33d64c782c3dda2cd51ef | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|lung / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 196 | 148 | 7 | 2ce8a787f2731faa913d20342d73041d59468f27 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling-mes_proliferating1_(3)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | df366d76ea55f49e349d622effa57c1535df8400 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_cycling|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | 1d2e0b328eb822db7521b5f5724d4bd17c0bad5f | |
| ToppCell | cycling_basal_cell|World / shred by cell class for nasal brushing | 4.26e-06 | 196 | 148 | 7 | aa7bac70a2fe4a3cb28d89fa1a87c68c2ead1349 | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | 1964c5003a0cb84539850a7cfe3bbb0e23a61d2d | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_cycling|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 4.26e-06 | 196 | 148 | 7 | 73f951f7712e0aa3323676b9a4b7944d21d347c4 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Macrophage_Dendritic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.26e-06 | 196 | 148 | 7 | cbc727b55b6433a701b1a331028a49960fcee6ee | |
| ToppCell | COVID-19-lung-Proliferative_fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.26e-06 | 196 | 148 | 7 | ca91d5e325875e7444809b80fcbd491d8899ea36 | |
| ToppCell | ICU-SEP-Lymphocyte-T_NK-T_NK_proliferative|ICU-SEP / Disease, Lineage and Cell Type | 4.40e-06 | 197 | 148 | 7 | 908e91fa16134b61943aea5e8fc0d6fbac8a8c6e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.40e-06 | 197 | 148 | 7 | 6ca6e17b7cc5f7ea8d4b6ca1ff670969bee65a45 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling-mes_proliferating3_(7)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.40e-06 | 197 | 148 | 7 | 84ed777cdba569200a3ef1654d8a12f17fcfb7f1 | |
| ToppCell | mild_COVID-19-B_intermediate|mild_COVID-19 / disease group, cell group and cell class (v2) | 4.40e-06 | 197 | 148 | 7 | f669500120646f69355a6f920b892a6f2faeab63 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_cycling|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.40e-06 | 197 | 148 | 7 | 8b616cde333bdbc0c591035ad9e4949155866245 | |
| Drug | haloperidol; Down 200; 10uM; MCF7; HT_HG-U133A | STARD13 RC3H2 ATAD5 RANBP3 CEMIP2 LINS1 RAB3GAP1 VPS13D BRCA2 BRWD1 | 5.77e-07 | 199 | 144 | 10 | 6963_DN |
| Drug | 2,4,4'-trichlorobiphenyl | TRPC7 CPNE9 DOCK11 ATAD5 ICE2 ANKS1B SOSTDC1 SMC2 KIF20B GFRA2 GIMAP8 ZFHX4 CELF1 BRCA2 KCND2 ARHGEF7 MICAL2 FANCI SCN1A KCNMA1 TLN2 ATM CHURC1 TOP2A BORA | 2.62e-06 | 1411 | 144 | 25 | ctd:C081766 |
| Drug | 2,4,5,2',5'-pentachlorobiphenyl | TRPC7 CPNE9 DOCK11 ATAD5 ICE2 ANKS1B SOSTDC1 SMC2 KIF20B GFRA2 GIMAP8 ZFHX4 CELF1 BRCA2 KCND2 ARHGEF7 MICAL2 FANCI SCN1A KCNMA1 TLN2 ATM CHURC1 TOP2A BORA | 3.80e-06 | 1441 | 144 | 25 | ctd:C009828 |
| Drug | phentolamine; Down 200; 11.5uM; MCF7; HT_HG-U133A_EA | 4.33e-06 | 195 | 144 | 9 | 1138_DN | |
| Drug | prochlorperazine dimaleate salt; Down 200; 10uM; MCF7; HT_HG-U133A | 4.71e-06 | 197 | 144 | 9 | 6975_DN | |
| Drug | Sanguinarine [2447-54-3]; Down 200; 12uM; MCF7; HT_HG-U133A | 3.01e-05 | 191 | 144 | 8 | 4168_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Up 200; 7uM; HL60; HT_HG-U133A | 3.49e-05 | 195 | 144 | 8 | 3028_UP | |
| Drug | Triamterene [396-01-0]; Down 200; 15.8uM; HL60; HT_HG-U133A | 3.62e-05 | 196 | 144 | 8 | 1861_DN | |
| Drug | Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; MCF7; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 6222_DN | |
| Drug | Bucladesine sodium salt [16980-89-5]; Down 200; 7.8uM; PC3; HT_HG-U133A | 3.76e-05 | 197 | 144 | 8 | 5886_DN | |
| Drug | troglitazone; Down 200; 10uM; MCF7; HT_HG-U133A_EA | 3.89e-05 | 198 | 144 | 8 | 1070_DN | |
| Drug | Asiaticoside [16830-15-2]; Down 200; 4.2uM; HL60; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 2943_DN | |
| Drug | Pergolide mesylate [66104-23-2]; Down 200; 9.8uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 7031_DN | |
| Drug | (R)-Propranolol hydrochloride [13071-11-9]; Up 200; 13.6uM; PC3; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 5814_UP | |
| Drug | DL-PPMP; Up 200; 2uM; MCF7; HT_HG-U133A_EA | 3.89e-05 | 198 | 144 | 8 | 1121_UP | |
| Drug | Benzocaine [94-09-7]; Down 200; 24.2uM; MCF7; HT_HG-U133A | 3.89e-05 | 198 | 144 | 8 | 4808_DN | |
| Drug | tertiary carboxamide | 3.97e-05 | 2 | 144 | 2 | CID006419719 | |
| Drug | 3,5-cholestadien-7-one | 3.97e-05 | 2 | 144 | 2 | CID000011280 | |
| Drug | Corticosterone [50-22-6]; Down 200; 11.6uM; PC3; HT_HG-U133A | 4.04e-05 | 199 | 144 | 8 | 4064_DN | |
| Drug | Sulfapyridine [144-83-2]; Down 200; 16uM; PC3; HT_HG-U133A | 4.18e-05 | 200 | 144 | 8 | 7151_DN | |
| Disease | Adenoid Cystic Carcinoma | 1.48e-04 | 100 | 147 | 5 | C0010606 | |
| Disease | Bilateral Wilms Tumor | 4.03e-04 | 29 | 147 | 3 | C2930471 | |
| Disease | FEV/FEC ratio | STARD13 BOC TET2 AMPD3 DIPK1A SH3BP2 SLC35B3 ANKS1B CEMIP2 DST KLHL7 COPS8 NETO1 CCSER2 RAI14 PLCL1 | 4.29e-04 | 1228 | 147 | 16 | EFO_0004713 |
| Disease | obsessive-compulsive symptom measurement | 4.92e-04 | 31 | 147 | 3 | EFO_0007802 | |
| Disease | disease of cellular proliferation (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:14566 (implicated_via_orthology) | |
| Disease | infertility (implicated_via_orthology) | 5.09e-04 | 7 | 147 | 2 | DOID:5223 (implicated_via_orthology) | |
| Disease | aspergillosis (is_implicated_in) | 6.77e-04 | 8 | 147 | 2 | DOID:13564 (is_implicated_in) | |
| Disease | female breast cancer (is_implicated_in) | 6.77e-04 | 8 | 147 | 2 | DOID:0050671 (is_implicated_in) | |
| Disease | Nephroblastoma | 7.67e-04 | 36 | 147 | 3 | C0027708 | |
| Disease | endometrial cancer (is_implicated_in) | 7.67e-04 | 36 | 147 | 3 | DOID:1380 (is_implicated_in) | |
| Disease | facial depth measurement | 8.67e-04 | 9 | 147 | 2 | EFO_0007857 | |
| Disease | colorectal cancer | STARD13 BOC TET2 AMPD3 ABCA12 TRPC6 ADGRB3 PIWIL4 C8orf34 PLCL1 | 9.30e-04 | 604 | 147 | 10 | MONDO_0005575 |
| Disease | colorectal cancer, colorectal adenoma | 1.01e-03 | 152 | 147 | 5 | EFO_0005406, MONDO_0005575 | |
| Disease | Peripheral T-Cell Lymphoma | 1.08e-03 | 10 | 147 | 2 | C0079774 | |
| Disease | Fanconi anemia (is_implicated_in) | 1.08e-03 | 10 | 147 | 2 | DOID:13636 (is_implicated_in) | |
| Disease | colorectal cancer (is_marker_for) | 1.16e-03 | 157 | 147 | 5 | DOID:9256 (is_marker_for) | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 1.47e-03 | 45 | 147 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | nicotine dependence (implicated_via_orthology) | 1.57e-03 | 12 | 147 | 2 | DOID:0050742 (implicated_via_orthology) | |
| Disease | Oligospermia | 1.57e-03 | 12 | 147 | 2 | C0028960 | |
| Disease | Medulloblastoma | 2.00e-03 | 50 | 147 | 3 | C0025149 | |
| Disease | forced expiratory volume | BOC TET2 AMPD3 ATAD5 TRIM39 CEP63 SLC9A2 DST CELF1 KCNMA1 PLCL1 | 2.06e-03 | 789 | 147 | 11 | EFO_0004314 |
| Disease | Fanconi anemia | 2.16e-03 | 14 | 147 | 2 | cv:C0015625 | |
| Disease | Cleft palate, cleft lip | 2.82e-03 | 279 | 147 | 6 | EFO_0003959, HP_0000175 | |
| Disease | executive function measurement | 2.86e-03 | 376 | 147 | 7 | EFO_0009332 | |
| Disease | age at menarche | 3.02e-03 | 594 | 147 | 9 | EFO_0004703 | |
| Disease | Bardet-Biedl syndrome 1 (disorder) | 3.19e-03 | 17 | 147 | 2 | C2936862 | |
| Disease | perinatal necrotizing enterocolitis (biomarker_via_orthology) | 3.19e-03 | 17 | 147 | 2 | DOID:8677 (biomarker_via_orthology) | |
| Disease | Bone marrow hypocellularity | 3.58e-03 | 18 | 147 | 2 | C1855710 | |
| Disease | Bardet-Biedl syndrome | 3.58e-03 | 18 | 147 | 2 | cv:C0752166 | |
| Disease | Prostatic Neoplasms | 3.84e-03 | 616 | 147 | 9 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 3.84e-03 | 616 | 147 | 9 | C0376358 | |
| Disease | Hereditary Non-Polyposis Colon Cancer Type 2 | 3.99e-03 | 19 | 147 | 2 | C1333991 | |
| Disease | Colorectal cancer, hereditary nonpolyposis, type 1 | 3.99e-03 | 19 | 147 | 2 | C2936783 | |
| Disease | Disorder of eye | 4.28e-03 | 212 | 147 | 5 | C0015397 | |
| Disease | Severe Combined Immunodeficiency | 4.42e-03 | 20 | 147 | 2 | C0085110 | |
| Disease | Adenocarcinoma of prostate | 4.42e-03 | 20 | 147 | 2 | C0007112 | |
| Disease | allergic rhinitis | 4.48e-03 | 133 | 147 | 4 | EFO_0005854 | |
| Disease | MYELODYSPLASTIC SYNDROME | 4.60e-03 | 67 | 147 | 3 | C3463824 | |
| Disease | BREAST CANCER | 4.86e-03 | 21 | 147 | 2 | 114480 | |
| Disease | osteoarthritis, hip, osteoarthritis, knee, total joint arthroplasty | 4.86e-03 | 21 | 147 | 2 | EFO_0004616, EFO_0010726, EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| DASAATKSMNCLARK | 1536 | Q96QE3 | |
| NFTSAMSIIKKACLT | 416 | Q9HCE6 | |
| AQKDKMFSQNDTRCA | 316 | P02750 | |
| CEMDVAKSFTQNKDL | 476 | Q6P2P2 | |
| SFAFTAAKLCDKMAL | 426 | O43310 | |
| QSIEELKDNFKLMCT | 191 | Q9NPI1 | |
| SMNELSNPCLKKENS | 1261 | O60242 | |
| QQLMEDKTSRFTCKG | 126 | P08319 | |
| SKKCTENDIRVMFSS | 116 | Q92879 | |
| DAMKEFCNLSLSERS | 616 | Q86UK0 | |
| LSETCFQLKKQMLES | 121 | Q9H116 | |
| AIMATATSRNCDKLK | 321 | P78314 | |
| KKLLAAMLSQDSFES | 331 | Q49A92 | |
| NMLLATKQICKEFTD | 336 | P05549 | |
| KKDQSTCLMQLFQSD | 711 | Q5JTC6 | |
| KSMAAFKNLSAQCQE | 436 | Q14155 | |
| TKSCMLQADSEKLRQ | 336 | Q15057 | |
| NKEEKIQLAYAMSCS | 851 | Q6Q4G3 | |
| NIFDCMDSTKTFSQL | 136 | Q6ZW61 | |
| KDKLSASFCQTLKAM | 1541 | P58397 | |
| LCNELSFLSDAMKSE | 746 | Q01432 | |
| CFKVTKRDEDSSLMQ | 251 | Q9HBD1 | |
| VLQMQCKLFVFDKTS | 401 | Q9H6Z4 | |
| ENQCSLDMKSKLNTS | 1046 | Q5TC82 | |
| SSYCSVIENMNKEKA | 581 | Q9P0K7 | |
| SACLLSDMESFKAAN | 676 | Q15042 | |
| LKAKFCSTVANDVML | 246 | Q8TDF5 | |
| KHKNCMESFLEAASL | 561 | P52333 | |
| ENFLCDLMDTAVTKK | 451 | Q7Z6G8 | |
| VSTQAFCSMKRKDIS | 471 | Q7RTW8 | |
| ENSREDALFCKSLMN | 1016 | Q9NVI1 | |
| SMSRDNKFSKKDCLS | 61 | Q460N3 | |
| SKLTEMPAKSFNQCV | 346 | Q9H511 | |
| CLKTLKEEFQQDMSR | 726 | O95461 | |
| LFSSSDKFTLNQDMC | 946 | Q8NEZ4 | |
| SAKVDSKLICMFQNS | 126 | Q8NG48 | |
| SKLICMFQNSDKLLS | 131 | Q8NG48 | |
| SMDKSLEFITNCGKN | 1221 | Q16787 | |
| KECILASLNIKSMQF | 941 | Q12791 | |
| NKCEAPALSFSDKTM | 2251 | Q03001 | |
| KNMDGTFNVTSCLKL | 201 | Q68D85 | |
| TFSCGDKLTLDQLKM | 841 | Q99665 | |
| MDQDSLSSSLKTCYK | 31 | P37268 | |
| FNSITMKDEDLINKC | 111 | Q9P1W3 | |
| MSLKKQVFAELSAVC | 386 | Q08426 | |
| DNKFIACLMSTKTEE | 1196 | Q9UHC1 | |
| EKKTISFQGCMAQLF | 116 | Q8NGL6 | |
| LVNEKDASCKRNAFM | 181 | P53618 | |
| LKSHMENTFKCNDKA | 786 | Q96Q89 | |
| KRMTSQDCLETSKND | 556 | Q8TC05 | |
| DLFSCEELKQSAKRM | 141 | Q8IY47 | |
| NSRSSLNAKMEECVK | 571 | Q9NZV8 | |
| DKACNLMIFDTRKTA | 76 | Q9H8J5 | |
| VADNMELSKSATCKN | 1056 | Q8NG31 | |
| KMCVDFLKEQVDASN | 131 | Q8IXQ5 | |
| EEALSNCMQADKTKA | 166 | Q96N16 | |
| TSCGIKKIMFQTNDD | 61 | A0A2R8Y4Y8 | |
| KMALCTNNITDFTVK | 726 | A8MWY0 | |
| KVEKCAMISSFLDQQ | 111 | O60244 | |
| KKQLSAMNSDELISF | 931 | Q9Y6X9 | |
| KDVKTALQRFMTNLC | 296 | Q8NGP2 | |
| KSINCEKMVRSQSFS | 211 | Q9H7U1 | |
| QNKLCFIQFTKKMES | 181 | O95876 | |
| NSCHKVMEFKSLLLS | 3806 | Q9P2D7 | |
| LMNDIADICKSLASF | 811 | Q13315 | |
| SQQFSECMDLALKSL | 141 | Q6EBC2 | |
| SAKKCAQDYNMLSDD | 156 | Q659A1 | |
| FSNVMICETKARKSS | 801 | Q9BWV1 | |
| SELKDMFRKFIQACS | 1981 | Q5JSL3 | |
| EMEKTCSKEFKLSNN | 2121 | P51587 | |
| KANNSKELSMCFTEL | 411 | O00451 | |
| ILNCMAVKLSDSEFK | 431 | Q5THR3 | |
| SATCKQLSQELMEKY | 361 | Q96MT8 | |
| CEVESKSQAFNMKQD | 526 | Q6PGQ7 | |
| TMQLCANKLDKKDFF | 151 | Q8IYJ1 | |
| ELCKMNKEDFLRATT | 166 | Q01543 | |
| FKSKFSDQTVIKMCQ | 36 | Q8ND71 | |
| SDMQACSQDKAKISL | 961 | Q5VT06 | |
| AATDSKDISNCMAKA | 1156 | Q9UHN6 | |
| CAATAANKIKLMSDV | 1931 | Q9NSI6 | |
| NSNSSCMELSKKIAE | 26 | O60256 | |
| MAESAFSFKKLLDQC | 6 | Q99627 | |
| CKSAKDNSMTLLQAT | 236 | Q9NYL5 | |
| KNSSVEAFKRQTECM | 631 | P42892 | |
| LKDKEDNCMVNSNLS | 441 | Q49AJ0 | |
| LQNSTLMAEFSKLCS | 91 | Q4V328 | |
| LMCDTSAKNLGYNDK | 291 | Q5T7M9 | |
| NMFKTCRLAKELLDS | 821 | Q92622 | |
| EEICSSKLNMSNKEY | 126 | Q504Y0 | |
| AKSSMVIKVDFCADQ | 196 | Q6ZTR5 | |
| LCALSFQKSTMESKD | 76 | Q3KP66 | |
| RDVATMQFCANKLDK | 176 | Q9HCH3 | |
| MSDANLDSSKKNFLE | 1 | Q7Z7J5 | |
| KSMANQLLAKFEEST | 716 | O94851 | |
| TAMCNEVASLSKKFT | 491 | Q8IWE2 | |
| IEKKLAFDMATNAAC | 171 | Q92882 | |
| EQLKMDFNDSASLSK | 446 | Q6S8J7 | |
| SNVMDVKDRSFLKSC | 206 | Q93086 | |
| TFLMQIDQETKKCTF | 291 | O14926 | |
| DRKKNVQCSFMLDSV | 156 | Q9Y6R4 | |
| MKNLLTEKCISSHNF | 1 | A8K8P3 | |
| TKMTNSTIKQLLAFC | 141 | Q9P1P4 | |
| NTLNKCASMKLDVNF | 111 | Q9Y3M8 | |
| CLQSGFEMLKDVKST | 251 | Q9HCM9 | |
| ITCFDEAQKKIFNLM | 146 | P49798 | |
| NTEKSNMLEFKLCPD | 1626 | Q9HCM1 | |
| TAQDKAVKCNMDSLR | 286 | Q587J7 | |
| NEDAKAAMTELKSCR | 56 | P0DMR2 | |
| NKQDFMDLSICTREK | 76 | Q7Z3Z4 | |
| SIMKKSEFLCCQDSF | 951 | O14802 | |
| IECSKITMDLKFNNS | 26 | Q9H1N7 | |
| DCLINAAKTSMSSKI | 146 | P17987 | |
| LKAKFCSTVANDVML | 251 | Q8NC67 | |
| MNFSEVFKLSSLLCK | 1 | Q9P2S5 | |
| VCNDLSIMSKFKLLS | 251 | Q9BVR0 | |
| DVDIRFSKTMNSCKV | 631 | Q13972 | |
| LDDLNNKKDSCMSNH | 1051 | P35498 | |
| SADFFQSCQKMRSIK | 506 | Q15399 | |
| SSIMKCDTDIQNKLY | 281 | Q8TDG2 | |
| AVCSKRDFMLITNKS | 31 | Q8WUH1 | |
| ESKMACAAQNASLLK | 156 | Q5QGZ9 | |
| DIQAFFMSIDSLCKK | 61 | Q495C1 | |
| SEKKISSANDCISFM | 101 | Q15111 | |
| MSNLQLKVLKACFSD | 2891 | Q86UP3 | |
| LFFSQINMCESKEKT | 6 | Q9NS28 | |
| NKLCVSALAMDSFAE | 796 | Q6ZVD8 | |
| LFKSFCQMKTIETID | 256 | Q9UBY0 | |
| FKCFTKKMDDSALQL | 431 | Q96RF0 | |
| EMCKDSQLEFKRVSA | 26 | Q7Z6L1 | |
| MDTSSKENIQLFCKT | 1 | Q9NYB5 | |
| FLETCLEKMQKDTSA | 466 | Q6IQ55 | |
| NDMDKQKSTLVDALC | 1111 | P29144 | |
| FFTTCSDLNMLKKLK | 51 | Q9BTF0 | |
| KAMLVCSDAATNKNF | 286 | O75326 | |
| NEDAKAAMTELKSCI | 56 | Q8TD33 | |
| TTFVCDNMDNAKKVA | 626 | O95347 | |
| ILMKSCLAFKNDATE | 16 | Q6X4U4 | |
| SADFFQSCQKMRSIK | 511 | Q9Y2C9 | |
| DCMKKFLDALELSQS | 1741 | P78527 | |
| DETINACKTMKSRSF | 1426 | Q7Z4N2 | |
| CITFQPDLSKFKMQS | 216 | P11388 | |
| KAVSDMLTACKQASF | 2211 | Q9Y4G6 | |
| NKFMSVLDTNKDCEV | 56 | P33764 | |
| STDNAKQLFRMKTSC | 476 | Q9Y210 | |
| LECMKNNLPSNDSSK | 31 | P17480 | |
| KLAAMLNTCSFQKPE | 306 | Q6N021 | |
| KMLEESKTLNFNCVD | 61 | Q9HCX4 | |
| ERSKQECFLNLKMAS | 1276 | Q5THJ4 | |
| IMSQCFDRSELSDKK | 581 | O00159 |